Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Human Genome Sciences, Inc. (HGSI) -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (1090)	8/25/2009 10:10:49 AM
From: tom pope	Read Replies (2) \| Respond to of 1127

Somebody read your posts. Stock has given back a lot of the early gains in the past 10 minutes.

To: kenhott who wrote (1090)	8/25/2009 4:28:02 PM
From: kenhott	Read Replies (1) \| Respond to of 1127

Honestly I didn't think I would get over $19 for my HGSI positions. I am now out of my long options also. Trying to not be greedy and to remember to say thank you. The line between good and lucky is a tough one to draw. GSK is the natural company to takeover HGSI because of their relationships. But anyone who has worked on more than one takeover knows this is never easy. It takes two to tango and both sides are trying to get more than half the pie. HGSI knows more about the 2nd phase 3 than anyone, including GSK. HGSI mgt has never been shy about thinking big. So one has to think about what is going on inside GSK AND HGSI. My short position is like a sold Sept ~30 put. Constructed because there is no regular Sept 30 puts. I believe there is only a small chance that a takeover, if coming, could be concluded by that time. I thought about Oct but didn't think it was worth the extra risk/return even thought Oct 30 Puts were available w/o extra work.